Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 3/2004

01.11.2004 | Original Article

Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary

verfasst von: Anita Chudecka-Głaz, Izabella Rzepka-Górska, Barbara Kosmowska

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 3/2004

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The aim of this work was to determine gonadotropin (LH, FSH) levels in serum and cyst fluid in various type of ovarian epithelial neoplasms (benign, borderline, malignant) and to compare them with levels in benign cysts. Additionally we decided to estimate if there were some significant correlations between serum and ovarian cyst fluid in gonadotropin levels in all investigated groups.

Materials and methods

The study group included 74 patients before (n=36) and after (n=38) menopause, divided into four groups depending on the histopathologic diagnosis. Serum and cyst fluid levels of LH and FSH were determined in all patients.

Results

We found statistically significant differences concerning LH and FSH levels in serum and cyst fluid between malignant and borderline tumors, between malignant tumors and benign cystadenomas and between malignant tumors and non-neoplastic cysts. We also found statistically significant correlations between serum and cyst fluid as to FSH and LH levels in patients with borderline tumors. There were no statistically significant correlations between serum and cyst fluid as to FSH and LH levels in patients with malignant epithelial tumors (group 1) and in patients with benign cystadenomas (group 3).

Conclusions

High FSH and LH levels in cyst fluid of malignant epithelial tumors of the ovary are in line with the gonadotropin theory of tumor growth. Simultaneous determination of various types inhibin levels appears to be an interesting topic for our future research.
Literatur
1.
Zurück zum Zitat Blaakaer J, Micic S, Morris ID, Hording U, Bennett P, Toftager-Jansen K et al (1993) Immunoreactive inhibin-production in post-menopausal women with malignant epithelial ovarian tumors. Eur J Obstet Gynecol Reprod Biol 52:105–110PubMed Blaakaer J, Micic S, Morris ID, Hording U, Bennett P, Toftager-Jansen K et al (1993) Immunoreactive inhibin-production in post-menopausal women with malignant epithelial ovarian tumors. Eur J Obstet Gynecol Reprod Biol 52:105–110PubMed
2.
Zurück zum Zitat Blaakaer J, Baeksted M, Micic S, Albrectsen P Rygaard J, Bock J (1995) Gonadotropin-releasing hormone agonist suppression of ovarian tumorigenesis in mice of the Wx/Wv genotype. Biol Reprod 53:775–779PubMed Blaakaer J, Baeksted M, Micic S, Albrectsen P Rygaard J, Bock J (1995) Gonadotropin-releasing hormone agonist suppression of ovarian tumorigenesis in mice of the Wx/Wv genotype. Biol Reprod 53:775–779PubMed
3.
Zurück zum Zitat Chudecka-Głaz A, Rzepka-Górska I, Kosmowska B, Głaz C (1999) The levels of selected hormones in serum and in ovarian cyst fluid at girls and young women. Ginekol Pol 70:236–241PubMed Chudecka-Głaz A, Rzepka-Górska I, Kosmowska B, Głaz C (1999) The levels of selected hormones in serum and in ovarian cyst fluid at girls and young women. Ginekol Pol 70:236–241PubMed
4.
Zurück zum Zitat Cramer DW, Barbieri RL, Muto MD, Kelly A, Brucks JP, Harlow BL (1994) Characteristics of women with a family history of ovarian cancer. Cancer 74:1318–1322PubMed Cramer DW, Barbieri RL, Muto MD, Kelly A, Brucks JP, Harlow BL (1994) Characteristics of women with a family history of ovarian cancer. Cancer 74:1318–1322PubMed
5.
Zurück zum Zitat Emons G, Weis S, Grundker C, Schultz KD (2000) LHRH might act as a negative autocrine regulator of proliferation of human ovarian cancer. Eur J Endocrinol 142:665–670PubMed Emons G, Weis S, Grundker C, Schultz KD (2000) LHRH might act as a negative autocrine regulator of proliferation of human ovarian cancer. Eur J Endocrinol 142:665–670PubMed
6.
Zurück zum Zitat Irmer G, Burger C, Muller R, Ortmann O, Peter U, Kakar SS et al (1995) Expression of the messenger RNAs for luteinizing releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma. Cancer Res 55:817–822PubMed Irmer G, Burger C, Muller R, Ortmann O, Peter U, Kakar SS et al (1995) Expression of the messenger RNAs for luteinizing releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma. Cancer Res 55:817–822PubMed
7.
Zurück zum Zitat Ivarsson K, Sundfeldt K, Brannstrom M, Hellberg P, Janson PO (2001) Diverse effects of FSH and LH on proliferation of human ovarian surface epithelial cells. Hum Reprod 16:18–23CrossRefPubMed Ivarsson K, Sundfeldt K, Brannstrom M, Hellberg P, Janson PO (2001) Diverse effects of FSH and LH on proliferation of human ovarian surface epithelial cells. Hum Reprod 16:18–23CrossRefPubMed
8.
Zurück zum Zitat Kramer S, Leeker M, Jager W (1998) Gonadotropin levels in ovarian cyst fluids: a predictor of malignancy? Int J Biol Markers 13:165–168 Kramer S, Leeker M, Jager W (1998) Gonadotropin levels in ovarian cyst fluids: a predictor of malignancy? Int J Biol Markers 13:165–168
9.
Zurück zum Zitat Kurbacher CHM, Jager W, Kurbacher JA, Bittl A, Wildt L, Lang N (1995) Influence of human luteinizing hormone cell growth and CA 125 secretion of primary epithelial ovarian carcinoma in vitro. Tumor Biol 16:374–384 Kurbacher CHM, Jager W, Kurbacher JA, Bittl A, Wildt L, Lang N (1995) Influence of human luteinizing hormone cell growth and CA 125 secretion of primary epithelial ovarian carcinoma in vitro. Tumor Biol 16:374–384
10.
Zurück zum Zitat Kuroda H, Mandai M, Konishi I, Yasuichiro Y, Tsuruta Y, Hamid A et al (1998) Human chorionic gonadotropin (hCG) inhibits cisplatin-inducted apoptosis in ovarian cancer cells: possible role of up-regulation of insuline-like growth factor-1 by hCG. Int J Cancer 76:571–578CrossRefPubMed Kuroda H, Mandai M, Konishi I, Yasuichiro Y, Tsuruta Y, Hamid A et al (1998) Human chorionic gonadotropin (hCG) inhibits cisplatin-inducted apoptosis in ovarian cancer cells: possible role of up-regulation of insuline-like growth factor-1 by hCG. Int J Cancer 76:571–578CrossRefPubMed
11.
Zurück zum Zitat Lagiou P, Ye W, Wedren S, Ekbom A, Nyren O, Trichopoulos D, Adami HO (2001) Incidence of ovarian cancer among alcoholic women: cohort study in Sweden. Int J Cancer 91:264–266CrossRefPubMed Lagiou P, Ye W, Wedren S, Ekbom A, Nyren O, Trichopoulos D, Adami HO (2001) Incidence of ovarian cancer among alcoholic women: cohort study in Sweden. Int J Cancer 91:264–266CrossRefPubMed
12.
Zurück zum Zitat Mandai M, Konishi I, Kuroda H, Fukumoto M, Komatsu T, Yamamoto S et al (1997) Messenger ribonucleic acid expression of LH/hCG receptor gene in human ovarian carcinomas. Eur J Cancer 33:1501–1507CrossRefPubMed Mandai M, Konishi I, Kuroda H, Fukumoto M, Komatsu T, Yamamoto S et al (1997) Messenger ribonucleic acid expression of LH/hCG receptor gene in human ovarian carcinomas. Eur J Cancer 33:1501–1507CrossRefPubMed
13.
Zurück zum Zitat Ohtani K, Sakamoto H, Kikuchi A, Nakayama Y, Idei T, Igarshi N, Matukawa T, Satoh K (2001) Follicle-stimulating hormone promotes the growth of human epithelial ovarian cancer cells through the protein kinase C-mediated system. Cancer Lett 166:207–213CrossRefPubMed Ohtani K, Sakamoto H, Kikuchi A, Nakayama Y, Idei T, Igarshi N, Matukawa T, Satoh K (2001) Follicle-stimulating hormone promotes the growth of human epithelial ovarian cancer cells through the protein kinase C-mediated system. Cancer Lett 166:207–213CrossRefPubMed
14.
Zurück zum Zitat Reimer T, Gerber B, Kunkel S, Luettich K (1997) Estradiol, gonadotropins and tumor markers in ovarian cyst fluid. Acta Obstet Gynecol Scand 76:478–483PubMed Reimer T, Gerber B, Kunkel S, Luettich K (1997) Estradiol, gonadotropins and tumor markers in ovarian cyst fluid. Acta Obstet Gynecol Scand 76:478–483PubMed
15.
Zurück zum Zitat Rzepka-Górska I, Kośmider M, Bulsa M, Kosmowska B, Malecha J (1994) LHRH analogues in epithelial ovarian cancer treatment. Ginekol Pol Suppl 3:1659–1661 Rzepka-Górska I, Kośmider M, Bulsa M, Kosmowska B, Malecha J (1994) LHRH analogues in epithelial ovarian cancer treatment. Ginekol Pol Suppl 3:1659–1661
16.
Zurück zum Zitat Schiffenbauer YS, Abramowitch R, Meier G, Nevo N, Holzinger M, Itin A et al (1997) Loss of ovarian function promotes angiogenesis in human ovarian carcinoma. Proc Natl Acad Sci USA 94:13203–13208CrossRefPubMed Schiffenbauer YS, Abramowitch R, Meier G, Nevo N, Holzinger M, Itin A et al (1997) Loss of ovarian function promotes angiogenesis in human ovarian carcinoma. Proc Natl Acad Sci USA 94:13203–13208CrossRefPubMed
17.
Zurück zum Zitat Wimalsena J, Dostal R, Meehan D (1992) Gonadotropins, estradiol and growth factors regulate epithelial ovarian cancer cell growth. Gynecol Oncol 46:345–350PubMed Wimalsena J, Dostal R, Meehan D (1992) Gonadotropins, estradiol and growth factors regulate epithelial ovarian cancer cell growth. Gynecol Oncol 46:345–350PubMed
Metadaten
Titel
Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary
verfasst von
Anita Chudecka-Głaz
Izabella Rzepka-Górska
Barbara Kosmowska
Publikationsdatum
01.11.2004
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 3/2004
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-003-0519-4

Weitere Artikel der Ausgabe 3/2004

Archives of Gynecology and Obstetrics 3/2004 Zur Ausgabe

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

Prämenstruelle Beschwerden mit Suizidrisiko assoziiert

04.06.2024 Suizidalität Nachrichten

Manche Frauen, die regelmäßig psychische und körperliche Symptome vor ihrer Menstruation erleben, haben ein deutlich erhöhtes Suizidrisiko. Jüngere Frauen sind besonders gefährdet.

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.